| Combination of genetic and quantitative serological immune markers are associated with complicated Crohnʼs disease behavior: |
trensh14 |
May 3, 2015 6:09:15 AM |
| Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn’s disease |
elee14 |
May 3, 2015 5:31:47 AM |
| Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis |
mgomez14 |
May 1, 2015 7:45:01 AM |
| Crohn's disease |
jzoza001 |
May 1, 2015 5:40:49 AM |
| Real-time tool to display the predicted disease course and treatment response for children with Crohnʼs disease: |
trensh14 |
May 1, 2015 12:16:39 AM |
| Have We Changed the Natural History of Pediatric Crohn's Disease with Biologics? |
trensh14 |
Apr 30, 2015 9:44:09 PM |
| Selected loss of tolerance evidenced by Crohn's disease–associated immune responses to auto- and microbial antigens |
trensh14 |
Apr 25, 2015 12:38:51 AM |
| A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease |
trensh14 |
Apr 25, 2015 12:43:55 AM |
| Current and future role of biomarkers in Crohn’s disease risk assessment and treatment |
trensh14 |
Apr 25, 2015 12:32:21 AM |
| Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn’s disease |
trensh14 |
Apr 25, 2015 12:30:50 AM |
